Dr. Noureddin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9350 Campus Point Dr
La Jolla, CA 92037Phone+1 800-926-8273Fax+1 702-671-6430
Education & Training
- David Geffen School of Medicine at UCLAClass of 2016
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- CA State Medical License 2019 - 2025
- NV State Medical License 2020 - 2023
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsA Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia.Maral Amangurbanova, Daniel Q Huang, Nabil Noureddin, Kaleb Tesfai, Richelle Bettencourt
Alimentary Pharmacology & Therapeutics. 2025-02-01 - 5 citationsMonitoring disease progression in metabolic dysfunction-associated steatotic liver disease.Nabil Noureddin, Nedret Copur-Dahi, Rohit Loomba
Alimentary Pharmacology & Therapeutics. 2024-06-01 - 2 citationsNatural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease.Nabil Noureddin, Daniel Q Huang, Ricki Bettencourt, Harris Siddiqi, Abdul M Majzoub
Alimentary Pharmacology & Therapeutics. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: